OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 04:26:49 2024-05-14 EDT | ||
| 2.22 EUR | +1.83% |
|
| Current month | +2.83% | ||
| 1 month | +73.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-05-14 | 2.22 | +1.83% |
| 24-05-13 | 2.18 | +9.55% |
| 24-05-10 | 1.99 | +2.05% |
| 24-05-09 | 1.95 | +3.17% |
| 24-05-08 | 1.89 | +4.42% |
Real-time BOERSE MUENCHEN
Last update May 14, 2024 at 04:26 am
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GQ55TY |
| ISIN | DE000GQ55TY2 |
| Date issued | 2023-09-20 |
| Strike | 117.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.33 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.61 € |
|---|---|
| Lowest since issue | 0.83 € |
| Spread | 0.05 € |
| Spread % | 2.20% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
140.8
USD
Average target price
146.7
USD
Spread / Average Target
+4.23%
- Stock Market
- Certificates
- Certificat